跳至主要内容
临床试验/NCT04570891
NCT04570891招募中不适用

Ultrasound-guided Fascia Iliaca Compartment Block for Proximal Femoral Osteotomy in Pediatric Patients: a Randomized Controlled Trial

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2020年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
36
试验地点
1
主要终点
total opioid consumption at 12 hours after the end of surgery

研究概览

简要总结

This prospective randomized controlled trial aims to examine the effect of fascia iliaca compartment block on the postoperative pain and opioid consumption in pediatric patients (3y≤ age <18y) who will undergo orthopedics surgery (proximal femoral osteotomy).

Patients will be allocated to either the FICB(Fascia iliaca compartment block + IV PCA) group or the control group (no block + IV PCA). Fascia iliaca compartment block will be performed using 0.25% ropivacaine (1mL/kg, MAX 30mL) under ultrasound-guidance at the end of surgery.

The total opioid consumption at 12, and 24 hours after the surgery, and the pain score at 10 min after PACU admin, 1,6,24 hours after the surgery, the total dose of additional rescue analgesia (intravenous ketorolac or nalbuphine) at 12 and 24 hours after the surgery will be recorded.

详细描述

This prospective randomized controlled trial aims to examine the effect of fascia iliaca compartment block on postoperative pain and opioid consumption in pediatric patients (3y≤ age <18y) who will undergo orthopedics surgery (proximal femoral osteotomy).

Patients will be allocated to either the FICB(Fascia iliaca compartment block + IV PCA) group or the control group (no block + IV PCA). Fascia iliaca compartment block will be performed using 0.25% ropivacaine (1mL/kg, MAX 30mL) under ultrasound-guidance at the end of surgery.

The total opioid consumption at 12, and 24 hours after the surgery, and the pain score at 10 min after PACU admin, 1,6,24 hours after the surgery, the total dose of additional rescue analgesia (intravenous ketorolac or nalbuphine) at 12 and 24 hours after the surgery will be recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
3 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 36 children aged between 3 and 18 years who undergo proximal femoral osteotomy

排除标准

  • Complex surgery (other than proximal femoral osteotomy)
  • Allergy to opioid
  • Allergy to local anesthetics
  • Disease in heart, lung, kidney, and liver
  • Coagulation disorder
  • Disease in the central and peripheral nervous system
  • Unstable vital sign
  • Significant renal impairment (Creatinine> 3.0 mg/dl)
  • Significant hepatic impairment (aspartate transaminase> 120 unit/L, alanine aminotransferase> 120 unit/L)

结局指标

主要结局

total opioid consumption at 12 hours after the end of surgery

时间窗: at 12 hours after the end of surgery

total opioid consumption at 12 hours after the end of surgery (IV Nalbuphine 1mg = IV Morphine 1mg = IV Fentanyl 10mcg (0.01mg) per kilogram of body weight.

次要结局

  • total opioid consumption at 24 hours after the end of surgery(at 24 hours after the end of surgery)
  • Numeric rating scale(10 minutes after the PACU admin, 1hour, 6hours, and 24hours after the end of surgery.)
  • Total additional dose of ketorolac(at 12hours, and 24hours after the end of surgery.)
  • pupil constriction velocity (CV)(at 1 hour after the end of surgery)
  • Total additional dose of nalbuphine(at 12hours, and 24hours after the end of surgery.)
  • The incidence of side effects of ropivacaine(within 1 hour after the end of surgery)
  • Hospital stay(within 14 days after the end of surgery)
  • Neurological Pupil indexTM (NPi)(at 1 hour after the end of surgery)
  • Intact toe sensory at the second postoperative day (POD-2)(At the second postoperative day (POD-2))
  • Wong-Baker Faces Pain Rating Scale(at 10 minutes after the PACU admin, 1hour, 6hours, and 24hours after the end of surgery.)
  • The incidence of side effects of analgesic medications(within 24 hours after the end of surgery)
  • Normal capillary refill time (< 3 seconds) at the second postoperative day (POD-2)(At the second postoperative day (POD-2))
  • Extensor hallucis longus function (motor power of extension of the big toe: I-V) at the second postoperative day (POD-2)(At the second postoperative day (POD-2))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jin-Tae Kim

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验